RNSH

Renishaw plc

RNSHF.US renishaw.com
69.11
+0.00 (+0.00%)
USD · PINK
52-week range
41.95
73.71
Trading at 86% of the 52-week range
Market Cap
5.03B
P/E Ratio
50.08
Forward P/E
25.32
Book Value
17.01
Div. Yield
1.50%
% Institutions
40.35%
% Insiders
53.13%

1 Year

+64.7%

3 Year

+57.7%

10 Year

+122.4%
Description

Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.

Company Information

Company Name
Renishaw plc
Sector
Technology
Industry
Scientific & Technical Instruments
Exchange
PINK
CUSIP: G75006117
Currency: USD
Full Time Employees: 4,975
Phone: 44 1453 524 524
Fiscal Year End: June
Description:

Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.

Address:

New Mills, Wotton-under-Edge, United Kingdom, GL12 8JR

People

Directors & Officers

Name Title Year Born
Mr. William Ernest Lee M.A., M.B.A. CEO & Director 1975
Mr. Daniel John Deer Co-Founder & Non-Executive Director 1938
Mr. John Francis Shipsey CFO & Executive Director 1964
Mr. Dave Wallace Director of Group Operations 1971
Mr. Kasim Ali Hussain Group General Counsel & Company Secretary NA
Mr. Chris Pockett Head of Communications NA
Ms. Clare Nicholls Group Human Resources Director NA
Mr. Rainer Lotz President of EMEA 1965
Andy Buttrey President of APAC NA
Mr. Rupert Jones Managing Director of Renishaw Medical NA

Financial Highlights

Market Cap: $5.03B
EBITDA: $122.01M
P/E Ratio: $50.08
Book Value: $17.01
Dividend/Share: $0.78
Dividend Yield: 1.50%
Earnings/Share: $1.38
Profit Margin: 10.06%
Operating Margin: 10.99%
ROA (TTM): 5.71%
ROE (TTM): 8.20%
Revenue (TTM): $737.26M
Revenue/Share (TTM): $10.13
Earnings Growth (YOY): -21.00%
Revenue Growth (YOY): 7.10%

Valuation Metrics

Enterprise Value: $4.69B
Trailing P/E: 50.08
Forward P/E: 25.32

Shares Statistics

Shares Outstanding: 72.76M
Shares Float: 33.88M
% Insiders: 53.13%
% Institutions: 40.35%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$713.04M
Cost of Goods Sold
adjust
$-382.21M
Gross Profit
subtotal
$330.83M
SG&A
adjust
$-77.10M
R&D
adjust
$-116.30M
Other Operating Expense
adjust
$-29.55M
Operating Income
subtotal
$107.89M
Other / Non-Operating Items
adjust
$-24.13M
Net Income
subtotal
$83.76M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RNSHF.US!